← Back to headlines
Belgian Pharma Giant Acquires US Epilepsy Treatment Firm
A major Belgian pharmaceutical company has completed the acquisition of an American firm specializing in treatments for epilepsy. This strategic move aims to expand the Belgian giant's portfolio in neurological disorders.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.



